Literature DB >> 17395669

B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans.

Domingo A Pascual-Figal1, María J Antolinos, Antoni Bayes-Genis, Teresa Casas, Francisco Nicolas, Mariano Valdés.   

Abstract

BACKGROUND: The association between B-type natriuretic peptide (BNP) and coronary artery disease is not fully understood.
OBJECTIVE: To assess whether ischaemia per se is a stimulus for BNP secretion.
SETTING: University tertiary hospital, Spain (Virgen de la Arrixaca).
DESIGN: Prospective interventional study. PATIENTS: 11 patients (55 (9) years, left ventricular ejection fraction (LVEF) 45% (7%) with a non-complicated anterior myocardial infarction (MI) and isolated stenosis of the left anterior descending (LAD) coronary artery, successfully treated by primary angioplasty.
INTERVENTIONS: 11.0 (0.9) days after MI, the LAD was occluded (20 min) for intracoronary infusion of progenitor cells. Blood samples were obtained from the femoral artery (peripheral circulation (PC)) and the coronary sinus (coronary circulation (CC)) immediately before and after coronary occlusion. MAIN OUTCOME MEASURES: BNP (pg/ml) was measured and ischaemia biomarkers were monitored.
RESULTS: During coronary occlusion, all patients experienced transitory chest pain and ST-segment dynamic changes. After coronary occlusion, lactic acid levels rose in CC (1.42 (0.63) -1.78 (0.68) ng/ml, p = 0.003). Myoglobin and cardiac troponin T did not differ in CC or PC at 24 h. No differences were found in LVEF (+0.18% (2.4)%, p = 0.86) and motion score index (-0.02 (0.06), p = 0.37). Before occlusion, BNP levels did not differ significantly in CC versus PC (253 (56) vs 179 (34), p = 0.093). After occlusion, BNP showed a significant increase in CC (vs 332 (61), p = 0.004), but no change occurred in PC (vs 177 (23), p = 0.93), and circulating BNP levels were higher in CC versus PC (p = 0.008).
CONCLUSIONS: In response to acute ischaemia, BNP levels immediately increase in coronary sinus but not at the peripheral level. BNP release in the coronary effluent may exert local beneficial effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395669      PMCID: PMC1955025          DOI: 10.1136/hrt.2006.101303

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  33 in total

1.  Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism.

Authors:  F Liang; D G Gardner
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

Authors:  J Koglin; S Pehlivanli; M Schwaiblmair; M Vogeser; P Cremer; W vonScheidt
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

3.  B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes.

Authors:  B S Rana; J I Davies; M M Band; S D Pringle; A Morris; A D Struthers
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

4.  Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Journal:  Circulation       Date:  2002-04-16       Impact factor: 29.690

5.  Natriuretic peptide system gene expression in human coronary arteries.

Authors:  Victor H Casco; John P Veinot; Mercedes L Kuroski de Bold; Roy G Masters; Michelle M Stevenson; Adolfo J de Bold
Journal:  J Histochem Cytochem       Date:  2002-06       Impact factor: 2.479

6.  Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty.

Authors:  J Tateishi; M Masutani; M Ohyanagi; T Iwasaki
Journal:  Clin Cardiol       Date:  2000-10       Impact factor: 2.882

7.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

Authors:  J A de Lemos; D A Morrow; J H Bentley; T Omland; M S Sabatine; C H McCabe; C Hall; C P Cannon; E Braunwald
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

8.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

9.  Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation.

Authors:  F Brunner; G Wölkart
Journal:  Microvasc Res       Date:  2001-01       Impact factor: 3.514

10.  Human bone marrow endothelial cells: a new identified source of B-type natriuretic peptide.

Authors:  Laurence Bordenave; Agnès Georges; Reine Bareille; Véronique Conrad; Franck Villars; Joelle Amédée
Journal:  Peptides       Date:  2002-05       Impact factor: 3.750

View more
  1 in total

1.  Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery.

Authors:  Huiqi Jiang; Henrik Hultkvist; Jonas Holm; Farkas Vanky; Yanqi Yang; Rolf Svedjeholm
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.